Current biology : CB 2012 Oct 9. pii: S0960-9822(12)01076-7.
Peschard, P; McCarthy, A; Leblanc-Dominguez, V; Yeo, M; Guichard, S; Stamp, G; Marshall, CJ
Oncogene Team, Division of Cancer Biology, Institute of Cancer Research, London SW3 6JB, UK.
RAL small GTPases, encoded by the Rala and Ralb genes, are members of the RAS superfamily of small GTPases and can act as downstream effectors of RAS . Although highly similar, distinct functions have been identified for RALA and RALB: RALA has been implicated in epithelial cell polarity , insulin secretion , GLUT4 translocation [4, 5], neurite branching, and neuronal polarity [6, 7], and RALB in tumor cell survival , migration/invasion [9-12], TBK1 activation , and autophagy . To investigate RAL GTPases in vivo, we generated null and conditional knockout mice. Ralb null mice are viable with no overt phenotype; the Rala null leads to exencephaly and embryonic lethality. The exencephaly phenotype is exacerbated in Rala(-/-);Ralb(+/-) embryos; embryos null for Rala and Ralb do not live past gastrulation. Using a Kras-driven non-small cell lung carcinoma mouse model, we found that either RALA or RALB is sufficient for tumor growth. However, deletion of both Ral genes blocks tumor formation. Either RALA or RALB is sufficient for cell proliferation, but cells lacking both fail to proliferate. These studies demonstrate functions of RAL proteins in development, tumorigenesis, and cell proliferation and show that RALA and RALB act in a redundant fashion.
The team at Ozgene has over two decades of experience creating customised knockout and knock-in mice for pivotal medical research globally. Over 350 scientific publications are based on research using Ozgene mice.